Project Grant HT94252310872

Award Date 9/15/23
Completion Date 9/14/25
Dollars Obligated $2.2M
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Santa Barbara, CA 93106, USA
Similar Awards
The Cooperative Agreement award, funded by the Uniformed Services University of the Health Sciences under the Uniformed Services University Medical Research Projects program (CFDA 12.750), is for the development of "SELF-DEPLOYING, INSTRUMENTED, SHAPE-MEMORY POLYMER ENDOTRACHEAL TUBES FOR NON- EXPERT, AUTONOMOUS EMERGENCY INTUBATION AND MONITORING OF THORACIC INJURIES IN BATTLEFIELD CONDITIONS". The $2,862,000.00 award, with a performance period from December 15, 2023 to December 14,...
The University of Maryland, Baltimore received a $308,821 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund the development of a novel medical device called the TRANSESOPHAGEAL AORTIC BLOOD FLOW OCCLUDER to control non-compressible torso hemorrhage from January 15, 2022 to January 14, 2024. The device aims to transform trauma care for service members and the public through innovative...
This Project Grant award, with a total funding of $5,963,305.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the continued clinical development of a novel pleural and tracheal sealant. The primary award recipient is the University of Vermont & State Agricultural College. A sub-award of an unspecified amount was provided to the University of Connecticut Health Center to support this research effort. The funding will...
This federal Project Grant award for $3,602,532.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports the development of a sustained-release drug delivery device to manage biofilm implant-related infection in the spine and lateral femur. The award was made to the University of Utah on September 30, 2024, with a planned completion date of September 29, 2028. A sub-award of unknown amount was made to Purgo Scientific LLC on...
This Project Grant award of $1,008,313.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research initiatives at the University of California, San Francisco (UCSF). The funding will enable UCSF to conduct innovative research focused on transforming healthcare for military service members and the broader public, with a particular emphasis on addressing critical medical challenges such as cancer,...
The Department of the Army Medical Command has awarded a $5,468,175 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Utah to develop a sustained-release drug delivery device to manage biofilm implant-related infections. The project, with a performance period from May 1, 2024 to April 30, 2028, will involve the University of Utah collaborating with Purgo Scientific LLC as a sub-awardee to advance this innovative medical technology. The...
This federal Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), provides $1,749,465.00 to Bright Uro, Inc. to develop a catheter-free, extended-monitoring urodynamics device for quantitative, real-time bladder management in spinal cord-injured patients. The award period runs from July 1, 2024 to June 1, 2026. The goal of this project is to create an innovative medical device that can assist in the care and treatment...
The University of California, San Diego (UCSD) has been awarded a $316,000.00 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). This two-year award, effective from February 1, 2024 to January 31, 2026, will support research to investigate "POSTVIRAL DYNAMICS AND DYSFUNCTION OF THE AUTONOMIC NERVOUS SYSTEM VIA ADHERENCE-INDEPENDENT LONGITUDINAL CARDIOPULMONARY MONITORING." The Military Medical...
The federal Cooperative Agreement award, issued by the Defense Advanced Research Projects Agency (DARPA) under the Research and Technology Development program (CFDA 12.910), aims to test the feasibility of managing a complex polytrauma patient using a single intravascular cannula placed by a field medic. The $1,863,335.00 award, with a performance period from September 27, 2024, to March 27, 2027, is being provided to the University of Maryland, Baltimore to develop and evaluate this novel...
The Department of the Army Medical Command, under the Military Medical Research and Development (CFDA 12.420) federal grant program, awarded a $1,999,583 Project Grant to IRR Inc. in Santa Barbara, CA. The grant supports an early-stage proof-of-concept study of a fixed-dose combination therapy in a high-fidelity porcine model of severe polytrauma. The project aims to transform healthcare for military service members and the broader public through innovative biomedical research. The performance...

The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $2,172,212.00 project grant to the University of California, Santa Barbara (UCSB) to develop a biomimetic, self-deploying intubation device for safer and more effective airway management in austere, far-forward environments. UCSB has engaged Vine Medical Inc. and Stanford University as sub-awardees to collaborate on this multi-year (Sep 2023 - Sep 2025) research and development effort. The project aims to advance the device technology through key milestones, including finalizing the design, completing verification and validation testing, submitting a premarket notification application to the FDA, and preparing for a post-market clinical study to demonstrate the device's dual-use capabilities for both military and civilian medical applications.

Generated 6/11/24, 11:45 AM